Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism

Fig. 5

Tracking the differentiation of hAD-MSCs in ovaries. The expression of ZP3 (a × 100 and × 800) and FSHR (b × 100 and × 800) in hAD-MSCs was observed at 8 weeks after hAD-MSC transplantation in ovaries. The yellow arrows indicate transplanted hAD-MSCs. Scale bars, 100 μm; Scale bars, 20 μm

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512